WEHI's researchers focus on solving complex biological questions and linking laboratory results to clinical outcomes. Partnerships and collaborations are key to advancing our drug discovery and development programs forward.

The Business Development Office develops and manages more than 500 agreements executed every year with local and international partners.

Partnership case studies

	Advancing drug discovery through skill sharing
	Paving the way for new inflammatory disease therapeutics
	Developing new cancer immunotherapies
	Targeting MCL-1, cancer’s Achilles heel
	Necroptosis research leads to spin-out company
	Developing targeted protein degraders into innovative cancer medicines